💊

Diapiotab

Tablet

🧬 Pioglitazone 🏢 Medimet Pharmaceuticals Ltd.
Generic Name Pioglitazone
Manufacturer Medimet Pharmaceuticals Ltd.
Unit Price Unit Price: ৳ 12.00 (50's pack: ৳ 600.00)

🔹 Indications

Diapiotab is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Diapiotab is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Pharmacology

Diapiotab is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Diapiotab is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Dosage & Administration

Diapiotab is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Diapiotab is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Interaction

Diapiotab is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Diapiotab is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Contraindications

Diapiotab is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Diapiotab is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Side Effects

Diapiotab is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Diapiotab is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Pregnancy & Lactation

Diapiotab is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Diapiotab is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Precautions & Warnings

Diapiotab is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Diapiotab is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Storage Conditions

Diapiotab is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Diapiotab is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

💡 Frequently Asked Questions

Diapiotab is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Diapiotab is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insuli...
Diapiotab is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Diapiotab is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insuli...
Diapiotab is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Diapiotab is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insuli...

User Reviews

No reviews yet!
Be the first to share your experience.

Write a Review